All Stories

  1. Exosome‐Associated MTA1 in Circulation Is Elevated During Breast Cancer Progression
  2. Abstract P5-09-05: Median Five-Year Follow-Up Outcomes Based on Pathologic Grade in a Multi-Institution Trial Using Intra-Operative Electronic Brachytherapy for Treatment of Early-Stage Breast Cancer
  3. Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-Medicare
  4. Abstract C061: Disparities in second breast cancers among women with ductal carcinoma in situ
  5. Abstract PO2-22-04: Median Five-Year Follow-Up Results from the Multi-Institution Trial for the Treatment of Early-Stage Breast Cancer Using Intra-Operative Electronic Brachytherapy
  6. Surgical Delay-Associated Mortality Risk Varies by Subtype in Loco-Regional Breast Cancer Patients in SEER-Medicare
  7. Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy
  8. Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature
  9. ASO Visual Abstract: Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer
  10. Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer
  11. Abstract P3-19-12: Impact of endocrine therapy (ET) noncompliance following intra-operative radiation therapy (IORT) in treatment of early-stage breast cancer patients (pts) enrolled in the ExBRT trial
  12. Women survive longer than men undergoing cytoreductive surgery and HIPEC for appendiceal cancer
  13. Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma
  14. ASO Author Reflections: Does Prompt Breast-Conserving Surgery Matter?
  15. A prospective single‐institution study of intraoperative radiotherapy (IORT) for early‐stage breast cancer
  16. Abstract 1120: Randomized clinical trial of a flaxseed lignan in pre-menopausal women at high risk for development of breast cancer
  17. Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast Cancer
  18. The importance of differentiating between qualitative, semi-quantitative, and quantitative imaging—close only counts in horseshoes
  19. FMTVDM/BEST Imaging Equally Applicable for Male Breast Cancer
  20. Measuring what's really happening in breast tissue without guessing.
  21. Renewable Portfolio Standards and Policy Stringency: An Assessment of Implementation and Outcomes
  22. Case Report: A Truck Driver with Pelvic Pain
  23. Plasma exosome microRNAs are indicative of breast cancer
  24. PO-0954: Early results of a multi-center trial of IORT using electronic brachytherapy for breast cancer
  25. Abstract P3-12-11: One-year follow-up results of a multi-center trial of intra-operative radiation therapy using electronic brachytherapy at the time of breast conservation surgery for early stage breast cancer
  26. Biopsy Techniques in Non-palpable or Palpable Breast Lesions
  27. Utilization of Surgery, Radiation Therapy and Systemic Therapy in the Management of Merkel Cell Carcinoma: A National Cancer Database Analysis
  28. Abstract 5205: Docosahexaenoic acid (DHA) alters breast cancer exosome-mediated microRNA signaling
  29. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA)
  30. Blocking the Adhesion Cascade at the Premetastatic Niche for Prevention of Breast Cancer Metastasis
  31. MINT: Multi-institutional, neoadjuvant therapy MammaPrint project.
  32. Do the CMS proposed breast cancer quality measures actually predict improved outcomes?
  33. Tamoxifen DownregulatesEtsOncogene Family MembersETV4andETV5in Benign Breast Tissue: Implications for Durable Risk Reduction
  34. The effects of clinical trials on improving breast cancer care at a single institution.
  35. An HLA-Presented Fragment of Macrophage Migration Inhibitory Factor Is a Therapeutic Target for Invasive Breast Cancer
  36. Mechanisms of Improved Outcomes for Breast Cancer between Surgical Oncologists and General Surgeons
  37. Surgical perspectives from a prospective, nonrandomized, multicenter study of breast conserving surgery and adjuvant electronic brachytherapy for the treatment of breast cancer
  38. Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysis
  39. Redefining Lumpectomy Using a Modification of the “Sick Lobe” Hypothesis and Ductal Anatomy
  40. The Optimization of Breast Conservation
  41. Use of electronic brachytherapy to deliver postsurgical adjuvant radiation therapy for endometrial cancer: a retrospective multicenter study
  42. Clinical Series of Oncoplastic Mastopexy to Optimize Cosmesis of Large-Volume Resections for Breast Conservation
  43. Mammary Ductoscopy
  44. Fibulin-4 and -5, but not Fibulin-2, are Associated with Tropoelastin Deposition in Elastin-Producing Cell Culture
  45. The Lobar Distribution of the Lesions in Breast Carcinoma: Ductoscopy and Surgery
  46. Focused Microwave Thermotherapy for Preoperative Treatment of Invasive Breast Cancer: A Review of Clinical Studies
  47. Reducing Surgical Morbidity by Pre-emptive Management
  48. Intraductal Approaches: Mammary Ductoscopy and Ductal Lavage to Assist in the Diagnosis of Breast Cancer
  49. 276-P: Monoclonal antibody specific for an ornithine decarboxylase peptide/HLA A*0201 complex confirms presentation of the peptide on primary breast tumor
  50. Breast Ductoscopy and the Evolution of the Intra-Ductal Approach to Breast Cancer
  51. Ductoscopy-Increasing Clinical Utility
  52. Breast Ductoscopy
  53. Who Wants a Blind Breast Surgeon?
  54. The Intraductal Approach to Breast Cancer
  55. Local Recurrence After Mastectomy in Patients With T3pN0 Breast Carcinoma Treated Without Postoperative Radiation Therapy
  56. Intraoperative Ductoscopy in Women Undergoing Surgery for Breast Cancer
  57. Hot Flash Therapies in Breast Cancer Survivors
  58. Who Wants a Blind Breast Surgeon?
  59. A Surgical Indication in Incurable Breast Cancer
  60. Fifteen-year series of skin-sparing mastectomy for stage 0 to 2 breast cancer
  61. The Future Prospect: Ductoscopy-Directed Brushing and Biopsy
  62. Understanding the mechanisms creating false positive lumpectomy margins
  63. Ductal Lavage: Risk Stratification Versus Cancer Detection
  64. Nonsurgical ablation of primary breast cancer
  65. Office-based breast ductoscopy for diagnosis
  66. Ductoscopy: Defining Its Role in the Management of Breast Cancer
  67. Focused microwave phased array thermotherapy for ablation of early-stage breast cancer: results of thermal dose escalation
  68. In brief
  69. Focused Microwave Phased Array Thermotherapy for Ablation of Early-Stage Breast Cancer: Results of Thermal Dose Escalation
  70. Success of sentinel lymph node mapping after breast cancer ablation with focused microwave phased array thermotherapy
  71. Breast cancer—have we been chasing the wrong target?
  72. Ductal lavage, nipple aspiration, and ductoscopy for breast cancer diagnosis
  73. Routine Operative Breast Endoscopy During Lumpectomy
  74. Association of maspin expression with the high histological grade and lymphocyte‐rich stroma in early‐stage breast cancer
  75. Ambulatory mastectomy
  76. Routine operative breast endoscopy for bloody nipple discharge
  77. Breast Enhanced Scintigraphy Testing Distinguishes Between Normal, Inflammatory Breast Changes, and Breast Cancer: A Prospective Analysis and Comparison With Mammography
  78. Ductal lavage and the clinical management of women at high risk for breast carcinoma
  79. Contour Abnormalities of the Abdomen after Breast Reconstruction with Abdominal Flaps
  80. Ductal Lavage for Detection of Cellular Atypia in Women at High Risk for Breast Cancer
  81. Expression of pp32 gene family members in breast cancer
  82. Long-term dynamics of chromosomal instability in cancer: A transition probability model
  83. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR
  84. Endoscopic Visualization of Breast Tumors
  85. A stochastic model of chromosome segregation errors with reference to cancer cells
  86. Ambulatory breast cancer surgery
  87. Surgery in breast cancer
  88. Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation
  89. Telomerase Activity and Prognosis in Primary Breast Cancers
  90. Surgery for breast cancer
  91. Hürthle Cell Neoplasms of the Thyroid
  92. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer
  93. DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma
  94. DNA content and other factors associated with ten‐year survival after resection of pancreatic carcinoma
  95. Thyroid-Specific Expression of Cholera Toxin A1 Subunit Causes Thyroid Hyperplasia and Hyperthyroidism in Transgenic Mice1
  96. Thyroid-Specific Expression of Cholera Toxin A1 Subunit Causes Thyroid Hyperplasia and Hyperthyroidism in Transgenic Mice
  97. Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Postoperative Adjuvant Chemoradiation Improves Survival
  98. pp32 overexpression induces nuclear pleomorphism in rat prostatic carcinoma cells
  99. Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 Patients
  100. Malignancies of the biliary tree
  101. P-glycoprotein status of favorable-histology Wilms' tumor predicts treatment outcome
  102. Impact of axillary lymph node dissection on the therapy of breast cancer patients.
  103. Evidence for altered cell‐cycle traverse of the non‐modal cells of the heteroploid MCa‐11 line
  104. Experience With Ambulatory Preoperative Bowel Preparation at The Johns Hopkins Hospital
  105. A comparison of flow cytometric and absorption cytometric DNA values as prognostic indicators for pancreatic carcinoma
  106. Non‐random distribution of abnormal mitoses in heteroploid cell lines
  107. Pancreatic Cancer Cell DNA Content Correlates With Long-term Survival After Pancreatoduodenectomy
  108. Use of Immediate Postoperative Mastectomy Prostheses
  109. Discrepancies among the metaphase, telophase, and the G0/G1 and G2 DNA peaks of heteroploid cell lines
  110. Is Preoperative Angiography Useful in Patients with Periampullary Tumors?
  111. Acid giemsa technique for rapid identification of mitotic cells.
  112. Early Versus Delayed Surgery in Gallstone Pancreatitis
  113. POSSIBLE ASSOCIATION BETWEEN RADIATION EXPOSURE AND CHROMOSOME CHANGES